| Demographic factors |
|
Private insurance (#, %, vs Medicaid) |
49 (76.6%) |
63 (77.8%) |
| Racial/ethnic minority |
31 (48.4%) |
40 (49.4%) |
| White |
37 (57.8%) |
47 (58.0%) |
| Black |
18 (28.1%) |
24 (29.6%) |
| Asian |
6 (9.4%) |
7 (8.6%) |
| Hispanic |
5 (7.8%) |
6 (7.4%) |
| Male infant gender |
31 (48.4%) |
39 (48.1%) |
| Maternal/antenatal factors |
|
Maternal parity at index pregnancy |
2 (1, 3) |
2 (1, 3) |
| Maternal age at delivery, years |
33.1 ± 7.3 |
33.0 ± 7.0 |
| Mulitple gestation |
38 (59.4%) |
44 (54.3%) |
| Antenatal steroids |
63 (98.4%) |
80 (98.8%) |
| Antenatal magnesium sulfate |
62 (96.9%) |
77 (95.1%) |
| PPROM |
24 (37.5%) |
30 (37.0%) |
| IUGR |
10 (15.6%) |
16 (19.8%) |
| Pre-eclampsia |
12 (18.8%) |
18 (22.2%) |
| Assisted reproductive technology |
28 (43.8%) |
32 (39.5%) |
| Cesarean delivery |
57 (89.0%) |
72 (88.9%) |
| Birth Characteristics |
|
Gestational age at birth (weeks) |
28.3 ± 2.2 |
28.4 ± 2.2 |
| Birth weight (g) |
1080 ± 270 |
1090 ± 270 |
| SGA |
4 (6.3%) |
7 (8.6%) |
| 1 min Apgar |
8 (5, 9) |
8 (6, 9) |
| 5 min Apgar |
9 (8, 9) |
9 (8, 9) |
| CRIB II Score |
8 (6, 11) |
8 (6, 11) |
| Morbidities of Prematurity |
|
Hypotension requiring pressors |
21 (32.8%) |
23 (28.4%) |
| Bronchopulmonary dysplasia |
25 (39.1%) |
28 (34.6%) |
| Necrotizing enterocolitis |
1 (1.6%) |
2 (2.5%) |
| Culture proven sepsis |
11 (17.2%) |
14 (17.3%) |
| Retinopathy of prematurity stage 2–4 |
12 (18.8%) |
12 (14.8%) |
| Intraventricular hemorrhage grade II-IV |
7 (10.9%) |
7 (8.6%) |
| PMA at NNNS assessment (weeks) |
34.6 ± 0.6 |
N/A |
